Hot Features
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment o... Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.22 | -4.41767068273 | 4.98 | 5.26 | 4.5 | 104530 | 4.77289144 | CS |
| 4 | -1.34 | -21.9672131148 | 6.1 | 6.12 | 4.295 | 145152 | 5.07934093 | CS |
| 12 | -2.84 | -37.3684210526 | 7.6 | 8.8 | 4.295 | 211533 | 6.24813651 | CS |
| 26 | 1.03 | 27.6139410188 | 3.73 | 8.8 | 3.506 | 154605 | 6.09206103 | CS |
| 52 | 2.95 | 162.983425414 | 1.81 | 12.46 | 1.566 | 812798 | 6.09962846 | CS |
| 156 | -1.93 | -28.8490284006 | 6.69 | 13.49 | 1.15 | 371425 | 6.80640937 | CS |
| 260 | 1.8996 | 66.4102922668 | 2.8604 | 15.27 | 0.327884 | 630677 | 6.99131276 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.